Related Experiment Video
Updated: May 4, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
33.9K
Medication Discrepancies During Transitions of Care: A Comparison Study
Summary
Primary care providers (PCPs) with admitting privileges (PCP-AD) had fewer medication discrepancies during care transitions than those without (PCP-NOAD). This suggests improved continuity of care when PCPs are involved in inpatient care.
Area of Science:
- Health Services Research
- Patient Care Coordination
- Medication Safety
Background:
- Transitions of care between inpatient and outpatient settings are associated with medication discrepancies.
- Effective communication and continuity of care are critical during these transitions.
Purpose of the Study:
- To compare medication discrepancies during care transitions between an outpatient clinic with admitting privileges (PCP-AD) and one without (PCP-NOAD).
Main Methods:
- Retrospective chart review of patients admitted between January and July 2009.
- Evaluation of medication discrepancies at admission, discharge, and PCP follow-up.
Main Results:
- PCP-AD demonstrated significantly lower rates of unacceptable medication discrepancies at both admission (63.4% vs. 90.3%) and discharge (44.9% vs. 84.1%) compared to PCP-NOAD.
- Patients on >10 medications had higher discrepancy rates.
- Higher follow-up rates were observed for PCP-AD patients (85% vs. 62.7%).
Conclusions:
- Direct PCP involvement in inpatient care is associated with improved continuity and reduced medication discrepancies.
- Accurate medication history is crucial regardless of the practice model.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
259
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
259
01:31Discharge Summary Forms
1.3K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
241
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
241
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
230
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
230
01:30Guidelines for Nursing Documentation I
2.5K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
2.5K